American Bio Medica

ABMC · OTC

Price unavailable right now.

No price history for this range.

About ABMC

American Bio Medica Corp. is a biotechnology company, which engages in the manufacture and sale of immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids. The company is headquartered in Kinderhook, New York. The firm is exploring strategic transactions which may result in entering into a new line of business (subject to specific competitive limitations under the Asset Sale to Healgen).

Employees
20
Headquarters
Kinderhook, New York
Listed
Oct 27, 1993
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
abmc.com

Leadership

American Bio Medica executives
NameTitleSince
Lawrence Ferringo——
Jean Neff—2008
Peter Jerome——

Revenue by product and region

Fiscal year ended Dec 31, 2022: $913.00K total revenue

By region

  • United States$806.00K88.3%
  • South America$79.00K8.7%
  • North America$24.00K2.6%
  • Europe$4.00K0.4%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

American Bio Medica suppliers and customers
CompanyRelationshipCorrelation
Co-Diagnostics CODXSupplier0.62
Zhejiang Orient Gene Biotech ASupplier-0.38
United StatesCustomer—
Lincoln Park Capital Fund, LLCSupplier and customer—

Similar companies

Companies in the same industry as American Bio Medica

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.